Back to User profile » Dr Fenghua Wang
Papers published by Dr Fenghua Wang:
Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer
Huang S, Huang L, Zhang D, Jiang Q, Wang F, Guo G
ImmunoTargets and Therapy 2025, 14:1097-1110
Published Date: 2 October 2025
PD-1-mAb Plus Regimen in the First and Second Lines of Advanced and Unresectable Biliary Tract Carcinoma: A Real-World, Multicenter Retrospective Analysis
Wang F, Wang FH, Sun K, Jiang C, Peng S, Xu LX, Kuang M, Guo GF, Chen SL
Journal of Inflammation Research 2022, 15:6031-6046
Published Date: 31 October 2022
A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
Yang LP, Wang ZX, He MM, Wu HX, Yuan SQ, Wang W, Jin Y, Ren C, Wang ZQ, Wang FH, Li YH, Wang F, Xu RH
Cancer Management and Research 2019, 11:3993-4003
Published Date: 2 May 2019
FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
Wang D, Wei X, Wang Z, Lu Y, Shi S, Wang N, Qiu M, Wang F, Wang RJ, Li Y, Xu R
OncoTargets and Therapy 2017, 10:5065-5076
Published Date: 19 October 2017
Role of capecitabine in treating metastatic colorectal cancer in Chinese patients
Wang F, Wang FH, Bai L, Xu RH
OncoTargets and Therapy 2014, 7:501-511
Published Date: 2 April 2014
